Medicare Enrolled

Dr. Manisha Kumar, D.O.

Rheumatology · San Diego, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3811 VALLEY CENTRE DR, San Diego, CA 92130
8587643465
In practice since 2006 (19 years)
NPI: 1164524088 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kumar

Dr. Manisha Kumar is a rheumatology specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kumar performed 69,578 Medicare services across 1,520 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kumar received a total of $1,637 from 13 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 8% volume in CA $1,637 industry payments

Medicare Practice Summary

Medicare Utilization ↗
69,578
Medicare services
Top 8% in CA for rheumatology
1,520
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,662 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 26,760 $5 $18
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
17,400 $17 $69
Denosumab injection (Prolia/Xgeva) 16,081 $18 $76
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
3,350 $34 $139
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
2,586 $30 $254
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
701 $1 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
535 $99 $350
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
338 $57 $236
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
315 $6 $39
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
298 $12 $46
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
288 $70 $393
Hyaluronan injection (Euflexxa) for joint
An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space.
243 $98 $1,148
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
119 $68 $248
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
112 $25 $100
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
101 $1 $41
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
94 $118 $479
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
88 $8 $14
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
87 $135 $453
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
35 $131 $491
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
33 $5 $12
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $88 $305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.6% high complexity
68.1% medium
1.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,637
Total received (2018-2024)
Avg $234/year across 7 years
Bottom 47% in CA for rheumatology
13
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,536 (93.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$101 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$155
2023
$337
2022
$156
2021
$113
2020
$119
2019
$330
2018
$428

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$84
Janssen Biotech, Inc.
$21
AstraZeneca Pharmaceuticals LP
$18
Genentech USA, Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Top 3 companies account for 79.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$469
Genentech USA, Inc.
$213
Novartis Pharmaceuticals Corporation
$165
AbbVie, Inc.
$145
Horizon Therapeutics plc
$134
Janssen Scientific Affairs, LLC
$119
AstraZeneca Pharmaceuticals LP
$113
Genentech, Inc.
$111
PFIZER INC.
$50
UCB, Inc.
$35
ABBVIE INC.
$34
Janssen Biotech, Inc.
$34
Lilly USA, LLC
$15
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
Actemra · COSENTYX · Cimzia · EVENITY · Enbrel · Humira · KRYSTEXXA · REMICADE · RINVOQ · Rituxan · SAPHNELO · SKYRIZI · Skyrizi · TALTZ · TREMFYA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in San Diego?
Compare rheumatologists in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
63
Per 100K population
1.9
County median income
$102,285
Nearest hospital
VA SAN DIEGO HEALTHCARE SYSTEM
5.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kumar is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kumar experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Kumar performed 26,760 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumar receive payments from pharmaceutical companies?
Yes. Dr. Kumar received a total of $1,637 from 13 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar's costs compare to other rheumatologists in San Diego?
Dr. Kumar's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →